This blog article will explore the new diabetes medication called Mounjaro, also known as Tirzepatide. Mounjaro is a new prescription medication used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes. It is also approved for weight loss in adults with overweight or obesity who have type 2 diabetes or are at high risk for developing type 2 diabetes. FDA approved Mounjaro in May 2022.
With its unique mechanism of action and potential benefits, Mounjaro is gaining attention as a breakthrough treatment option. In this comprehensive guide, we will delve into the details of what Mounjaro is, how it works, its benefits, potential side effects, and recommended dosage, and address some frequently asked questions.
What is Mounjaro?
Mounjaro, or Tirzepatide, is a novel medication that belongs to a class of drugs called glucagon-like peptide-1 receptor agonist (GLP-1RA). It is designed to help regulate blood sugar levels in individuals with type 2 diabetes. Mounjaro is administered as an injection and works by mimicking the effects of a naturally occurring hormone called GLP-1. This hormone helps stimulate insulin secretion, suppresses glucagon release, slows down gastric emptying, and promotes a feeling of fullness.
How does Mounjaro work?
Mounjaro works by targeting multiple pathways involved in glucose metabolism. Mounjaro works by targeting two hormones: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). GLP-1 and GIP are naturally produced in the body and help to regulate appetite and blood sugar levels. It enhances insulin secretion from the pancreas in response to elevated blood sugar levels. Additionally, Mounjaro inhibits glucagon release, which helps prevent excessive production of glucose by the liver. It also slows down stomach emptying, leading to reduced appetite and improved glycemic control. This comprehensive approach makes Mounjaro a powerful tool in managing type 2 diabetes.
What were the major findings of the clinical trial on Mounjaro?
In clinical trials, Mounjaro was shown to be effective for both weight loss and blood sugar control. In one study, people who took Mounjaro lost an average of 15% of their body weight over 68 weeks. In another study, people who took Mounjaro significantly reduced their A1C levels (a measure of blood sugar control – as much as a 2.4% reduction in HbA1c) compared to those who took a placebo.
What are the benefits of Mounjaro?
Mounjaro offers several potential benefits for individuals with type 2 diabetes. Here are some key advantages:
Improved Blood Sugar Control: By regulating insulin secretion and suppressing glucagon release, Mounjaro helps maintain stable blood sugar levels.
Weight Management: Mounjaro has been shown to promote weight loss by reducing appetite and delaying gastric emptying.
Once-Weekly Dosing: Mounjaro is being developed as a once-weekly injection, providing patients with convenience and ease of use.
Lower Hypoglycemia Risk: Compared to some other diabetes medications, Mounjaro has a lower risk of causing hypoglycemia, which is a condition characterized by dangerously low blood sugar levels.
What are the potential side effects of Mounjaro?
As with any medication, Mounjaro may have potential side effects. It’s important to note that not everyone will experience these side effects, and they may vary in severity. Common side effects associated with Mounjaro include:
- Nausea
- Vomiting
- Diarrhea
- Abdominal pain
- Decreased appetite
These side effects are usually mild and transient, resolving on their own over time. However, if you experience persistent or severe side effects, it is crucial to consult your healthcare provider for further guidance.
What is the recommended dose?
It is available in three doses: 2.5 mg, 5 mg, 10 mg, 12.5 mg and 15 mg. The starting dose is 2.5 mg once a week. The dose can be increased to 5 mg or 10 mg after four weeks, if needed. Mounjaro is injected under the skin of the abdomen, upper arm, or thigh. The recommended dosage of Mounjaro may vary depending on individual factors such as age, weight, and overall health. Following your healthcare provider’s instructions regarding dosing and administration is essential. Mounjaro is typically initiated at a lower dose and gradually increased to minimize the risk of side effects. Your healthcare provider will determine the most suitable dose for you based on your specific needs.
Can everyone take Mounjaro?
Mounjaro is not for everyone. It is not recommended for people with a history of pancreatitis or thyroid cancer. It is also not recommended for people who are pregnant or breastfeeding.
Urdu 
English